• About Us
  • Contact Us
  • Today Headline
  • Write for us
Today Headline
No Result
View All Result
  • breaking news today
    • Politics news
    • Sports
    • Science News & Society
  • Entertainment News
    • Movie
    • Gaming
  • Technology News
    • Automotive
    • Software & IT
  • Health News
    • Lifestyle
    • Insurance
  • Finance News
    • Money
  • Enterprise
  • Contact Us
  • breaking news today
    • Politics news
    • Sports
    • Science News & Society
  • Entertainment News
    • Movie
    • Gaming
  • Technology News
    • Automotive
    • Software & IT
  • Health News
    • Lifestyle
    • Insurance
  • Finance News
    • Money
  • Enterprise
  • Contact Us
No Result
View All Result
TodayHeadline
No Result
View All Result

GlaxoSmithKline’s results another test for boss Emma Walmsley

February 12, 2022
in Parenting
Reading Time: 3 mins read
53789991 10477917 image m 88 1644005372719 – TodayHeadline


GlaxoSmithKline’s full-year results another test for embattled boss Emma Walmsley as she continues to fend off attacks from activist investor Elliott

  • Investors will be keenly eyeing the firm’s outlook in next week’s results 

By Daily Mail City & Finance Reporter

Published: 16:54 EST, 4 February 2022 | Updated: 03:36 EST, 5 February 2022










GlaxoSmithKline’s full-year results on Wednesday will be another test for embattled chief executive Emma Walmsley as she continues to fend off attacks from activist investor Elliott Management. 

The company has been under increasing pressure over the planned de-merger of its consumer healthcare business, although an aborted £50billion swoop on the division by Unilever last month has helped push GSK’s shares to their highest levels in nearly two years.

The share price rise may have brought Walmsley some breathing space to pursue her strategy. However, the stock is still below pre-pandemic levels which is unlikely to appease Elliott or other shareholders.

53789991 10477917 image m 88 1644005372719 – TodayHeadline

Meanwhile, investors will be keenly eyeing the firm’s outlook in next week’s results. 

GSK upgraded its full-year guidance in October. But it is still forecasting a year-on-year decline in earnings. Investors will be hoping this has been narrowed further or potentially turned positive. Sales for 2021 are also expected to be around £34billion, about flat year-on-year, so any alterations will be closely watched. 

Also in focus will be the total dividend for the year, which GSK has previously targeted at 80p per share.

Meanwhile, GSK’s medicine and vaccine pipeline will continue to attract investor attention with around 63 products in development.

Key areas in focus will likely be infectious diseases, HIV and cancer drugs, particularly any updates on progress from ongoing clinical trials. 

Advertisement

Share or comment on this article:

Some links in this article may be affiliate links. If you click on them we may earn a small commission. That helps us fund This Is Money, and keep it free to use. We do not write articles to promote products. We do not allow any commercial relationship to affect our editorial independence.

  • Trending
  • Comments
  • Latest
fe8f40fd 12bf 4847 8e61 6d0dca7136fe gettyimages 899764870 – TodayHeadline

Cleaning A Kid’s Car Seat? Don’t Soak The Straps, Says Safety Advocate

The rise of crypto casinos – TodayHeadline

The rise of crypto casinos

Cashew Nut Recipes olivemagazine – TodayHeadline

Cashew Nut Recipes | olivemagazine

2a535e19 4118 4209 bae4 c516540f1c50 kathleen garrity 13 – TodayHeadline

A Mom’s Deeply Accurate Parody Of Vacationing With Kids Is Going Viral

McCarthy Celebrates 'Fabulous' Debt Ceiling Deal That Got More Democrat Votes Than Republican

McCarthy Celebrates ‘Fabulous’ Debt Ceiling Deal That Got More Democrat Votes Than Republican

file 20230519 25 hu8m2q – TodayHeadline

Billions is spent on cancer research globally – but is it money well spent?

turning a circle into – TodayHeadline

Kirigami-inspired formula provides blueprint for designing shape-shifting materials and devices

1685629221 w720h450 – TodayHeadline

ECB President Says Euro Zone Inflation Still ‘Too High’ as Rate Falls Lower than Expected to 6.1%

PopularStories

McCarthy Celebrates 'Fabulous' Debt Ceiling Deal That Got More Democrat Votes Than Republican
Politics news

McCarthy Celebrates ‘Fabulous’ Debt Ceiling Deal That Got More Democrat Votes Than Republican

file 20230519 25 hu8m2q – TodayHeadline
breaking news today

Billions is spent on cancer research globally – but is it money well spent?

turning a circle into – TodayHeadline
Technology News

Kirigami-inspired formula provides blueprint for designing shape-shifting materials and devices

1685629221 w720h450 – TodayHeadline
Money

ECB President Says Euro Zone Inflation Still ‘Too High’ as Rate Falls Lower than Expected to 6.1%

About Us

Todayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.

Follow Us

Latest News

McCarthy Celebrates 'Fabulous' Debt Ceiling Deal That Got More Democrat Votes Than Republican

McCarthy Celebrates ‘Fabulous’ Debt Ceiling Deal That Got More Democrat Votes Than Republican

file 20230519 25 hu8m2q – TodayHeadline

Billions is spent on cancer research globally – but is it money well spent?

turning a circle into – TodayHeadline

Kirigami-inspired formula provides blueprint for designing shape-shifting materials and devices

McCarthy Celebrates 'Fabulous' Debt Ceiling Deal That Got More Democrat Votes Than Republican

McCarthy Celebrates ‘Fabulous’ Debt Ceiling Deal That Got More Democrat Votes Than Republican

file 20230519 25 hu8m2q – TodayHeadline

Billions is spent on cancer research globally – but is it money well spent?

turning a circle into – TodayHeadline

Kirigami-inspired formula provides blueprint for designing shape-shifting materials and devices

  • Real Estate
  • Parenting
  • Cooking
  • NFL Games On TV Today
  • Travel and Tourism
  • Home & Garden
  • Pets
  • Privacy & Policy
  • Contact
  • About

© 2023 All rights are reserved Today headline

No Result
View All Result
  • Real Estate
  • Parenting
  • Cooking
  • NFL Games On TV Today
  • Travel and Tourism
  • Home & Garden
  • Pets
  • Privacy & Policy
  • Contact
  • About

© 2023 All rights are reserved Today headline